There are 2867 resources available
1650P - The interplay of peripheral circulating free DNA and platelet-to-lymphocyte ratio in patients with differentiated thyroid cancer with/without type 2 diabetes mellitus undergoing radioiodine therapy
Presenter: Adina Elena Stanciu
Session: Poster session 11
1118P - Real-world adjuvant treatment patterns in patients with stage I-III EGFR-mutated non-small cell lung cancer (NSCLC) in China: Interim analysis from the ADDRESS study
Presenter: Wenhua Liang
Session: Poster session 15
846P - Triple combination of ipilimumab + nivolumab + anti-TNF in treatment naive melanoma patients: Final analysis of TICIMEL, a phase Ib prospective clinical trial
Presenter: Nicolas Meyer
Session: Poster session 03
1651P - Comparison of surgical outcomes between synchronous lateral neck dissection and metachronous lateral neck dissection for clinically N1b papillary thyroid cancer
Presenter: Hyeok Jun Yun
Session: Poster session 11
1119P - Real-world efficacy and safety of anlotinib in combination with PD-1/PD-L1 inhibitors as first-line or second-line treatment in advanced non-small cell lung cancer
Presenter: Qiming Wang
Session: Poster session 15
847P - Precision oncology for resistant acral, mucosal and cutaneous melanomas: A prospective broad high throughput genomics feasibility study
Presenter: Serge Leyvraz
Session: Poster session 03
1652P - Molecular and pathological patterns of treatment failure in patients treated by RET selective inhibitors for metastatic medullary thyroid carcinoma
Presenter: Julien Hadoux
Session: Poster session 11
1120P - Medical practice analysis of sex-specific trends in advanced non-small cell lung cancer (NSCLC) in biomarker testing and treatment in Europe and Asia
Presenter: Carmen Escorial
Session: Poster session 15
848P - Second-line systemic treatment for patients with advanced melanoma: Results from the prospective real-world study GEM1801
Presenter: Ivan Marquez-Rodas
Session: Poster session 03